2022
DOI: 10.1007/s40204-022-00188-5
|View full text |Cite
|
Sign up to set email alerts
|

Application of non-metal nanoparticles, as a novel approach, for improving the stability of blood products: 2011–2021

Abstract: Despite the importance of the proper quality of blood products for safe transfusion, conventional methods for preparation and their preservation, they lack significant stability. Non-metal nanoparticles with particular features may overcome these challenges. This review study for the first time provided a comprehensive vision of the interaction of non-metal nanoparticles with each blood product (red blood cells, platelets and plasma proteins). The findings of this review on the most effective nanoparticle for … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 147 publications
(172 reference statements)
0
2
0
Order By: Relevance
“…In addition, the red blood cell membrane has enormous deformability and can pass through the microvascular system. 39 , 40 Hemolysis rate is the most basic measure of blood compatibility. When nanomaterials come into contact with red blood cells, the surface hydrophobic bonds and irregular shapes may damage the red blood cell membrane, leading to the release of heme and causing hemolysis.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the red blood cell membrane has enormous deformability and can pass through the microvascular system. 39 , 40 Hemolysis rate is the most basic measure of blood compatibility. When nanomaterials come into contact with red blood cells, the surface hydrophobic bonds and irregular shapes may damage the red blood cell membrane, leading to the release of heme and causing hemolysis.…”
Section: Discussionmentioning
confidence: 99%
“…Nanoparticles have become one such topic deserving close attention. Their huge variety (inorganic nanoparticles, organic nanoparticles, ceramic nanoparticles, and carbon-based nanoparticles [1][2][3][4][5][6]), biosynthesis simplicity, and remarkable physicochemical, biological, and catalytic properties can literally open a new era for the creation of modern drugs solving different biomedical tasks. The biological synthesis of nanoparticles by living organisms-bacteria, fungi, and plants [7]-is an inexhaustible source of medicines that enable the solving of large-scale problems in the treatment of various diseases-bacterial and viral infections, oncological diseases, parasitic invasions, inflammatory processes, diabetes, and also in biosensing, bioimaging, drug delivery, diagnostics, etc.…”
Section: Introductionmentioning
confidence: 99%